Completed NA INTERVENTIONAL 1-arm NCT03050112

Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital.

Sponsor: Pierre Wauthy

Updated 6 times since 2017 Last updated: Nov 20, 2017 Started: Feb 14, 2017 Primary completion: Jun 1, 2017 Completion: Jun 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Congenital Heart Disease and is currently completed. Pierre Wauthy leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

Status: Not Yet Recruiting → Completed

▶ Show 1 earlier version

Feb 2017 — Dec 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pierre Wauthy

Data source: Brugmann University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium